Foxtail millet (Setaria italica) alleviates non-alcoholic fatty liver disease in high-fat diet/streptozotocin-induced diabetic mice through gut microbiota modulation

被引:4
作者
Wang, Han [1 ]
Zhao, Qingyu [1 ]
Fu, Yongxia [2 ]
Liu, Zhenyu [1 ]
Zhu, Yiqing [1 ]
Wang, Chao [1 ]
Shen, Qun [1 ]
机构
[1] China Agr Univ, Coll Food Sci & Nutr Engn, Natl Ctr Technol Innovat Deep Proc Highland Barley, Natl Engn Res Ctr Fruit & Vegetable Proc, Beijing 100083, Peoples R China
[2] Shanxi Agr Univ, Shanxi Inst Funct Food, Taiyuan 030031, Peoples R China
关键词
Foxtail millet; NAFLD; Diabetes; Gut microbiota; SCFAs; INTESTINAL MICROBIOTA; GLUCOSE-METABOLISM; OBESITY; ACIDS; SUPPLEMENTATION; PREVALENCE; RESISTANCE; STEATOSIS; HEALTH; DIET;
D O I
10.1016/j.fbio.2023.102797
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Non-alcoholic fatty liver disease (NAFLD), caused by increased hepatic fat accumulation, inflammation, and oxidative stress, is one of the most common complications of diabetes. The hypoglycemic effect of foxtail millet supplementation has been studied previously. However, the influence of foxtail millet on diabetes-induced NAFLD remains unknown. The present study investigated the role of heat-treated foxtail millet (HFM) in alleviating NAFLD-related phenotypic indicators and altering gut composition in diabetic mice. Our disease model was established using a high-fat diet combined with streptozotocin before HFM supplementation. In diseased mice, the consumption of HFM reduced hepatic total cholesterol by 21.13%, triglyceride by 18.59%, malondialdehyde by 42.64%, and increased superoxide dismutase by 14.98% in the liver, respectively. Also, fasting blood glucose and serum insulin levels significantly decreased by 30.11% and 30.09%, respectively. 16S rRNA gene sequencing analysis indicated that HFM alleviated NAFLD-related gut microbiota dysbiosis in mice. Specifically, HFM treatment regulated gut microbiota composition, enriched probiotics (Bifidobacterium, Prevotellaceae_UCG-001, and Allobaculum), reduced harmful bacteria (Peptococcus, Oscillibacter, and EscherichiaShigella), and elevated short-chain fatty acid concentrations. These findings demonstrated that the beneficial effects of HFM on NAFLD may be associated with changes in gut microbiota composition.
引用
收藏
页数:9
相关论文
共 56 条
[31]   Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients [J].
Ryysy, L ;
Häkkinen, AM ;
Goto, T ;
Vehkavaara, S ;
Westerbacka, J ;
Halavaara, J ;
Yki-Järvinen, H .
DIABETES, 2000, 49 (05) :749-758
[32]   Diet as Regulator of Gut Microbiota and its Role in Health and Disease [J].
Sanchez-Tapia, Monica ;
Tovar, Armando R. ;
Torres, Nimbe .
ARCHIVES OF MEDICAL RESEARCH, 2019, 50 (05) :259-268
[33]   Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases [J].
Sanna, Serena ;
van Zuydam, Natalie R. ;
Mahajan, Anubha ;
Kurilshikov, Alexander ;
Vila, Arnau Vich ;
Vosa, Urmo ;
Mujagic, Zlatan ;
Masclee, Ad A. M. ;
Jonkers, Daisy M. A. E. ;
Oosting, Marge ;
Joosten, Leo A. B. ;
Netea, Mihai G. ;
Franke, Lude ;
Zhernakova, Alexandra ;
Fu, Jingyuan ;
Wijmenga, Cisca ;
McCarthy, Mark, I .
NATURE GENETICS, 2019, 51 (04) :600-+
[34]   Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1 [J].
Shi, Ameng ;
Li, Ting ;
Zheng, Ying ;
Song, Yahua ;
Wang, Haitao ;
Wang, Na ;
Dong, Lei ;
Shi, Haitao .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[35]  
Song LH, 2020, FOOD FUNCT, V11, P977, DOI [10.1039/C9FO01570A, 10.1039/c9fo01570a]
[36]   Inulin Can Alleviate Metabolism Disorders in ob/ob Mice by Partially Restoring Leptin-related Pathways Mediated by Gut Microbiota [J].
Song, Xiaofeng ;
Zhong, Liang ;
Lyu, Na ;
Liu, Fei ;
Li, Boxing ;
Hao, Yanan ;
Xue, Yong ;
Li, Jing ;
Feng, Yuqing ;
Ma, Yue ;
Hu, Yongfei ;
Zhu, Baoli .
GENOMICS PROTEOMICS & BIOINFORMATICS, 2019, 17 (01) :64-75
[37]   Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients [J].
Targher, Giovanni ;
Bertolini, Lorenzo ;
Padovani, Roberto ;
Rodella, Stefano ;
Tessari, Roberto ;
Zenari, Luciano ;
Day, Christopher ;
Arcaro, Guido .
DIABETES CARE, 2007, 30 (05) :1212-1218
[38]  
Thingholm LB, 2019, CELL HOST MICROBE, V26, P252, DOI 10.1016/j.chom.2019.07.004
[39]   Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade [J].
Tilg, Herbert ;
Adolph, Timon E. ;
Moschen, Alexander R. .
HEPATOLOGY, 2021, 73 (02) :833-842
[40]   Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis [J].
Tojo, Rafael ;
Suarez, Adolfo ;
Clemente, Marta G. ;
de los Reyes-Gavilan, Clara G. ;
Margolles, Abelardo ;
Gueimonde, Miguel ;
Ruas-Madiedo, Patricia .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (41) :15163-15176